Aspen Aerogels, Inc.
ASPN · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $0 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 89.6% | 32.4% | 48.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 40.4% | 23.8% | 2.8% | 8.2% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 11.4% | -9.3% | -37.9% | -22.5% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 3% | -19.2% | -45.9% | -30.5% |
| EPS Diluted | 0.17 | -0.66 | -2.19 | -0.92 |
| % Growth | 125.8% | 69.9% | -138% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |